BioNTech SE
Biotechnology company developing immunotherapies for cancer and infectious diseases.
BNTX | US
Overview
Corporate Details
- ISIN(s):
- US09075V1026
- LEI:
- Country:
- United States of America
- Address:
- AN DER GOLDGRUBE 12, 55131 MAINZ
- Website:
- https://www.biontech.com/
- Sector:
- Manufacturing
Description
BioNTech SE is a global biotechnology company pioneering novel therapies for cancer and infectious diseases. The company leverages its deep expertise in immunology to develop a diverse portfolio of therapeutic platforms. Its oncology pipeline includes mRNA-based cancer immunotherapies, next-generation immunomodulators, and targeted therapies, with a strategy focused on creating synergistic combinations. In infectious diseases, BioNTech applies its proprietary mRNA technology to develop vaccines, most notably co-developing the first authorized mRNA-based vaccine for COVID-19. The company's core mission is to translate scientific research into innovative treatments that harness the power of the immune system to improve or establish new standards of care for patients globally.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all BioNTech SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioNTech SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioNTech SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
